Microcap Ledger Microbot Medical Inc. $MBOT
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Hingham, MA
- Fiscal year end
- December 31
- Shares outstanding
- 67,164,801 [10-Q 2026-08-11]
What the company doesAI summary of filing
Microbot Medical Inc. is a medical device company that develops robotic endovascular surgical systems for minimally invasive procedures. The company's primary product is the LIBERTY Endovascular Robotic Surgical System, which received FDA 510(k) clearance in September 2025 and entered limited market release in November 2025. The company is pre-revenue from product sales but has received research and development grants from the Israeli Innovation Authority totaling approximately $2.5 million through December 31, 2025. Microbot also acquired the NovaCross technology platform from Nitiloop Ltd. in October 2022 and intends to develop additional robotic surgical solutions. [10-K 2026-03-26]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $346.0K | −$9.30M | −$10.04M | $3.15M | [10-Q 2026-08-11] |
| FY ended Dec 2025 | — | −$13.14M | −$13.05M | $3.91M | [10-K 2026-03-26] |
| FY ended Dec 2024 | — | −$11.44M | −$8.83M | $3.11M | [10-K 2026-03-26] |
- Quarterly cash burn
- −$5.02M
- Cash runway Estimate
- ~1.9 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-11 | 16,932,341 | [10-Q 2024-11-13] |
| 2025-03-24 | 34,744,476 | [10-K 2025-03-25] |
| 2025-05-12 | 36,377,812 | [10-Q 2025-05-14] |
| 2025-08-10 | 45,545,939 | [10-Q 2025-08-12] |
| 2025-11-12 | 67,158,044 | [10-Q 2025-11-12] |
| 2026-03-24 | 67,158,044 | [10-K 2026-03-26] |
| 2026-05-13 | 67,164,801 | [10-Q 2026-05-13] |
| 2026-08-11 | 67,164,801 | [10-Q 2026-08-11] |
- Shelf registration
- S-3 filed 2025-10-14; no effectiveness notice found in EDGAR [S-3 2025-10-14]
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2024-10-11. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2024-10-11 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-10-11] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-06 | 8-K | Regulation FD disclosure |
| 2026-09-28 | 8-K | Regulation FD disclosure |
| 2026-08-11 | 8-K | Regulation FD disclosure |
| 2026-08-11 | 10-Q | Quarterly report |
| 2026-08-07 | 8-K | Material agreement entered; Director or officer change |
| 2026-07-21 | 8-K | Regulation FD disclosure |
| 2026-07-07 | 8-K | Regulation FD disclosure; Other events |
| 2026-06-30 | 8-K | Regulation FD disclosure; Other events |
| 2026-06-25 | 8-K | Regulation FD disclosure |
| 2026-06-23 | 8-K | Regulation FD disclosure; Other events |
| 2026-06-16 | 8-K | Regulation FD disclosure |
| 2026-06-09 | 8-K | Regulation FD disclosure; Other events |
Alerts for $MBOT
Email me when Microbot Medical Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.